What ICH S6(R1): Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals requires
ICH S6(R1) establishes the framework for preclinical safety assessment of biologics including monoclonal antibodies, recombinant proteins, and gene therapies, requiring pharmacologically relevant species selection, integrated immunogenicity monitoring, tissue cross-reactivity studies, and risk-based determination of carcinogenicity and genotoxicity study requirements.
Pillar: Biotech & Genomics · Authority: ICH Safety Working Party (SWP) - International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use · Version: 1.1.0 · Last updated:
Primary source: https://www.ich.org/products/guidelines/safety/safety-single/article/s6.html
SHA-256 integrity: b8328344b14f92a51c2be13bdf01fa027b653ecf8307fe0cc24e625dafb7049b
Primary Citations — 7 traced to source
- {"title":"ICH S6(R1): Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals - Addendum to ICH S6","url":"https://www.ich.org/products/guidelines/safety/safety-single/article/s6.html","instrument":"ICH S6(R1) (June 2011)","authority":"International Council for Harmonisation (ICH)"}
- {"title":"ICH S6(R1) Full Guideline Text - Step 4 Final Document","url":"https://database.ich.org/sites/default/files/S6_R1_Guideline.pdf","instrument":"ICH S6(R1) Step 4","authority":"ICH"}
+ 5 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/ich-s6-r1-preclinical-safety-biotech-pharmaceuticals-2011.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/ich-s6-r1-preclinical-safety-biotech-pharmaceuticals-2011.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/ich-s6-r1-preclinical-safety-biotech-pharmaceuticals-2011
- Back to registry: Browse all 10,085 compliance nodes